BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3220012)

  • 1. Ampicillin plus sulbactam in vitro activity against anaerobes.
    Heilmann F; Heizmann W; Werner H
    Drugs; 1988; 35 Suppl 7():84-8. PubMed ID: 3220012
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
    Heizmann W; Heilmann F; Werner H
    Infection; 1987; 15(5):370-4. PubMed ID: 3692611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H; Heizmann W; Heilmann F
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association experiments in antimicrobial susceptibility testing of aerobes and anaerobes to ampicillin and ampicillin plus sulbactam.
    Heizmann WR; Werner H; Heilmann F
    J Chemother; 1989 Jul; 1(4 Suppl):315-6. PubMed ID: 16312418
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR; Heilmann F; Werner H
    Suppl Int J Gynecol Obstet; 1989; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
    Rezvan SP; Sidorenko SV; Budanov SV
    Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of meropenem compared with imipenem, metronidazole, ampicillin, and ampicillin/sulbactam against anaerobes.
    Schumacher U; Manncke B; Gerbracht K; Werner H
    Arzneimittelforschung; 1994 Jul; 44(7):859-62. PubMed ID: 7945523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms.
    Leone F; Morandotti MG; Mazzella P; Sanna A; Ravizzola G; Colombrita D; Pinzi G; Turano R; Menozzi MG; Lecchini R
    J Int Med Res; 1990; 18(3):191-200. PubMed ID: 2193834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro methods for testing susceptibility of anaerobes to ampicillin-sulbactam and amoxicillin-clavulanic acid.
    Fuchs PC; Barry AL; Jones RN
    J Clin Microbiol; 1988 Jun; 26(6):1246-7. PubMed ID: 3384939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of ampicillin/sulbactam against cefoxitin-resistant anaerobic bacteria.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1988 Jan; 21(1):135-8. PubMed ID: 3356620
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro efficacy of sulbactam combined with ampicillin against anaerobic bacteria.
    Wexler HM; Harris B; Carter WT; Finegold SM
    Antimicrob Agents Chemother; 1985 May; 27(5):876-8. PubMed ID: 2990330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of resistance to anaerobic organisms in Australia.
    Munro R
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB; Bartelt MA; Chan EL; Dalton HP
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriology of 100 consecutive diabetic foot infections and in vitro susceptibility to ampicillin/sulbactam versus cefoxitin.
    Borrero E; Rossini M
    Angiology; 1992 Apr; 43(4):357-61. PubMed ID: 1558322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.
    Finegold SM; Molitoris D; Väisänen ML
    Antimicrob Agents Chemother; 2009 Jan; 53(1):281-6. PubMed ID: 18955526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
    Sedallian A; Roudon T
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the in vitro effectiveness of sulbactam/ampicillin and ampicillin].
    Baykal M; Akalin E
    Mikrobiyol Bul; 1987 Jan; 21(1):16-9. PubMed ID: 3441224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A combination of ampicillin and sulbactam: effect on aerobic and anaerobic gram-negative bacteria].
    González C; García A; Urrea R; del Solar E; Bello H; Zemelman R
    Rev Med Chil; 1990 May; 118(5):548-54. PubMed ID: 2293275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evaluations of aminopenicillin/beta-lactamase inhibitor combinations.
    Jones RN
    Drugs; 1988; 35 Suppl 7():17-26. PubMed ID: 3265377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.